Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer

Abstract

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei

Background: RAD51 from the cluster genes which have a vital role in the pathogenesis of squamous cell carcinoma. Present study aimed to analysed polymorphisms of RAD5 single nucleotide 1(rs2619679, rs2928140 and rs1801320) and their relationship to breast cancer (BC) and ovarian cancer (OC) in Iraqi population. Methods: This study included, 35 females with BC, 35 females with OC, who were diagnostic histopathologicaly, and 30 healthy females as control. Three SNPs (rs2619679, rs2928140 and rs1801320) of RAD51 were selected for genotyping by using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: Statistically differences were found in the distribution of AA and TT genotypes and A/T alleles for rs2619679 in BC (p<0.05) so GG and CC genotypes and G/C alleles for rs2928140. Whereas distribution of genotypes and alleles for rs1801320 not reflect significant differences (p>0.05) between BC and control but mutant genotype GG and mutant allele G appeared in highest frequency (42%, 57%) in BC. Statistically changes of RAD51 SNPs for OC were found in the incidence of AA and T alleles for rs2619679 (p<0.05) so, GG and CC genotypes and G/C alleles for rs2928140 but distribution of genotypes and alleles for rs1801320 not reproduce significant differences (p>0.05) between OC and control but mutant genotype GG and mutant allele G appeared in OC with highest rate (45%, 59%). Mutant genotype/allele of rs2619679 (TT/T), rs2928140(CC/C) and rs1801320 (GG/G) appeared as effective factors for cancer with acceptable rate for diagnosis of BC and OC. Conclusion: mutation in RAD51 SNPs (rs2619679, rs2928140 , rs1801320) associated with increases the possibility of BC and OC.

 

How to Cite this Article
Pubmed Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei. Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer. SRP. 2020; 11(10): 100-108. 
doi:10.31838/srp.2020.10.17

Web Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei. Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer. http://www.sysrevpharm.org/?mno=10190 [Access: March 28, 2021]. doi:10.31838/srp.2020.10.17

AMA (American Medical Association) Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei. Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer. SRP. 2020; 11(10): 100-108. doi:10.31838/srp.2020.10.17



Vancouver/ICMJE Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei. Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer. SRP. (2020), [cited March 28, 2021]; 11(10): 100-108. doi:10.31838/srp.2020.10.17



Harvard Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei (2020) Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer. SRP, 11 (10), 100-108. doi:10.31838/srp.2020.10.17



Turabian Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei. 2020. Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer. Systematic Reviews in Pharmacy, 11 (10), 100-108. doi:10.31838/srp.2020.10.17



Chicago Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei. "Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer." Systematic Reviews in Pharmacy 11 (2020), 100-108. doi:10.31838/srp.2020.10.17



MLA (The Modern Language Association) Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei. "Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer." Systematic Reviews in Pharmacy 11.10 (2020), 100-108. Print. doi:10.31838/srp.2020.10.17



APA (American Psychological Association) Style

Maather Baqer Hussein Al-Harmooshee and Orass. M. Sh. Al-Taei (2020) Germline Mutation of RAD51 Single Nucleotide Polymorphisms as Susceptibility Factor for Breast and Ovarian Cancer. Systematic Reviews in Pharmacy, 11 (10), 100-108. doi:10.31838/srp.2020.10.17

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3